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KESAN EKSTRAK DAUN Moringa oleifera KE ATAS SITOTOSIK DAN 
LALUAN APOPTOSIS DALAM SEL KANSER PAYUDARA (MCF-7) 
 
ABSTRAK 
 
Moringa oleifera (MO) adalah daripada famili Moringaceae. Di Malaysia, 
MO dikenali sebagai pokok Munggai atau Kelor. MO terkenal dengan sifat-sifat 
terapeutik dan mempunyai pelbagai aktiviti biologi seperti antioksidan dan 
antikanser. Dalam kajian ini, daun MO telah diekstrak dengan pelarut yang 
mempunyai polariti berbeza. Kesan ekstrak 80 % metanol dan pecahan pelarut daun 
MO terhadap sitotosik sel MCF-7 telah diuji menggunakan ujian MTS. Sel normal 
payudara (MCF-10A) digunakan untuk perbandingan dengan sel MCF-7 dan 
memilih efektif ekstrak yang memberi kesan paling sitotosik pada sel MCF-7. Antara 
semua ekstrak, ekstrak diklorometan (DF-CME-MOL) telah dipilih berdasarkan IC50 
terendah iaitu 5 µg/mL dan nilai selektif indeks (SI) tertinggi iaitu 9.5. Kemudian, 
ekstrak yang dipilih (DF-CME-MOL) digunakan untuk analisis seterusnya. Analisis 
fitokimia dilakukan dengan menggunakan ujian DPPH, ABTS, Folin-kiokalteu, 
aluminium klorida dan analisis GC-MS. Kandungan antioksidan dalam DF-CME-
MOL untuk ujian DPPH dan ABTS adalah 10.52 ± 0.009 mg / g TEAC dan 4.32 ± 
0.021 mg / g TEAC, masing-masing. Manakala, jumlah kandungan fenolik dan 
flavanoid adalah 34.96 ± 0.006 mg / g GAE dan 15.72 ± 0.050 mg / g QUE, masing-
masing. Selepas itu, analisis kompoun oleh GC-MS mengesan beberapa potensi 
sebatian dalam DF-CME-MOL dinamakan; Fenol, 4-(metoksimetil)-, 2-Metoksi-4-
vinilfenol, Fenol, 2-propil, Fenol, 2-metoksi-4-(1-propenil)-, (Z)-, 4-((1E)-3-
Hidroksi-1-propenil)-2-metoksifenol, Asid Heksadekanoid, metil ester, Fenol, 2-[(4- 
hydroksifenil) metil], Fenol, 4, 4‟-metilenebis-, Fenol, 2-etil-, Benzinetanol, 
  
xvii 
 
4-hidroksi-, Benzaldehad, 4-hidroksi-, Benzinasetonitril, 4-hidroksi- dan 
Benzaldehad, 3,4-dimetoksi-. Kemudian analisis apoptosis dijalankan dengan 
menggunakan „Annexin V-FITC‟ melalui aliran analisis sitometri FACS dan 
seterusnya mengesahkan melalui „western blot‟ untuk mengesan isyarat laluan 
apoptosis menggunakan protein terpilih seperti p53, bax, sitokrom c dan caspase 8. 
DF-CME-MOL sangat mendorong induksi apoptosis awal melalui laluan ekstrinsik 
sel MCF-7. Oleh itu, daun MO mempunyai potensi untuk dikembangkan sebagai 
agen antikanser pada kanser payudara. 
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THE EFFECT OF Moringa oleifera LEAF EXTRACT ON CYTOTOXICITY 
AND APOPTOSIS PATHWAY IN BREAST CANCER CELL (MCF-7) 
 
ABSTRACT 
 
Moringa oleifera (MO) is belonging to Moringaceae family. In Malaysia, 
MO was known as „Munggai‟ or „Kelor‟ tree. MO is well known for its therapeutic 
properties that possesses a wide range of biological activities such as antioxidant and 
anticancer properties. The impact of different solvents of various degree of polarities 
on the cytotoxicity of breast cancer cell line (MCF-7), were studied. The cytotoxicity 
effect of 80 % methanol and its solvent fractions of Moringa oleifera leave (MOL) 
extract against MCF-7 cell were determined by using MTS assay. The normal breast 
cell line (MCF-10A) was used to compare with MCF-7 cell. The effective extract 
that gave the most cytotoxic effect on MCF-7 cell had been chosen. Among of all 
extracts, dichloromethane extract (DF-CME-MOL) had been selected accordingly to 
its lowest IC50 (5 µg/mL) and highest selectivity index (SI) (9.5). Then, the chosen 
extract (DF-CME-MOL) was proceed for further analysis. The phytochemical 
analysis was performed using DPPH, ABTS, Folin-Ciocalteu, aluminium chloride 
and GC-MS analysis. An antioxidant contents in DF-CME-MOL for DPPH and 
ABTS assay were 10.52±0.009 mg/g TEAC and 4.32±0.021 mg/g TEAC, 
respectively. While, total phenolic and flavonoid content were 34.96±0.006 mg/g 
GAE and 15.72±0.050 mg/g QUE, respectively. After that, compound analysis by 
GC-MS detected some potential compounds in DF-CME-MOL named; Phenol, 4-
(methoxymethyl)-, 2-Methoxy-4-vinylphenol, Phenol, 2-propyl, Phenol, 2-methoxy-
4-(1-propenyl)-, (Z)-, 4-((1E)-3-Hydroxy-1-propenyl)-2-methoxyphenol, 
Hexadecanoid acid, methyl ester, Phenol, 2-[(4-hydroxyphenyl) methyl], Phenol, 4,  
  
xix 
 
4‟-methylenebis-, Phenol, 2-ethyl-, Benzeneethanol, 4-hydroxy-, Benzaldehyde, 4-
hydroxy-, Benzeneacetonitrile, 4-hydroxy- and Benzaldehyde, 3,4-dimethoxy-. Then,  
apoptosis analysis was carried out by using Annexin V-FITC through flow cytometry 
FACS and further confirm by Western blot in detected the signalling of apoptosis 
pathway using selected proteins such as p53, Bax, Cytochrome c and Caspase 8. The 
DF-CME-MOL greatly induced early apoptosis through extrinsic pathway in MCF-7 
cells. Thus, MOL has a potential to be developed into anticancer agent on breast 
cancer.  
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Background of study 
The ductal carcinoma is a common type of breast cancer where it initiates 
either in the duct cell, lobules or tissues in the breast (Sharma et al., 2010). Once it 
starts to spread surround the tissue, it called invasive breast cancer. Commonly, 
breast cancer happens mostly among woman. However, it still happens rarely to man. 
According to American Cancer Society (2016) reported that the total of breast 
cancers occurrence in the USA are 246,660-woman and 2,600-man. Additionally, 
about 40,890 deaths caused by the disease. Nonetheless, it is worrying when breast 
cancer incidence is increasing in Malaysia and led as the main cancer disease where 
the statistics for breast cancer occurrence revealed an increasing about 30.4 % to 
47.5 % (International Agency for Research on Cancer, 2018). Surprisingly, 
International Agency for Research on Cancer (2018) shown that the rate of breast 
cancer occurrence in both sexes about 17.3 % which is the highest cancer incidence 
followed by colorectal (14 %), lung (10.7 %), nasopharyngeal (4.8 %) and liver 
(4.4 %). The high number of breast cancer incidence has increased awareness and 
conducting a research needed for better understanding to promote the human health. 
 
Treatment of breast cancer has several options to overcome that disease such 
as surgery, chemotherapy, radiation therapy, hormone therapy and targeted therapy 
(Komen, 2014). However, it depending on stage and type of cancer. Even so, each 
treatment option has possible risks and side effects. In addition, modern medicines 
and/or therapies offered nowadays are quite expensive and can be led to dangerous 
side effect toward patient‟s body system by causing of appetite loss, vomiting, 
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nausea, faintness, hair loss, bleeding, diarrhea, premature menopause, mouth 
soreness, and lowered resistance to infections (Siegel et al., 2012). 
  
Therefore, studies must be carried out to overcome current side effect by 
identifying potential medicinal plants which can help in reducing the symptom of 
side effect. Besides that, the medicinal plant is commonly believed to promote 
human health that might prevent chronic diseases like cancers (Martin et al., 2011). 
Thus, most researchers have focused on potential medicinal plants and a more 
detailed study is required to seek the safety of compound that contented natural 
ingredients of bioactive foods, nutrients or phytochemicals, (Fahey et al., 2012). In 
this study, we also interested with beneficial of medicinal plant namely Moringa 
oleifera (MO). 
 
In Malaysia, MO is known as Munggai or Kelor tree. However, it has a 
variety of names in different areas such as Horseradish tree, Drumstick tree, Miracle 
tree, Mother‟s best friend, and West Indian Ben (Fahey, 2005). The name given is 
based on the medicinal usage of Moringa oleifera (MO). MO is one of the medicinal 
plant that had been consumed by humans traditionally, especially in African and 
India as their folk remedies. This tree can be found around sub-Himalayan tracts of 
Africa, South, and Central American, Caribbean, Oceania, and Asia. Until now, it 
was widely grown at tropics and sub-tropics area either on loamy, sandy, or sandy-
loam with drought-tolerance (Leone et al., 2015).  
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Virtually all part of this tree: leaf, flower, fruit (pods), seed, seed oil, bark, 
gum, and root have been used for numerous ailments as folk remedies when it has 
been proved to exhibit an amount of nutrition. This tree contains of minerals, amino 
acids, vitamins, β-carotene, alkaloids, flavonoids and numerous phenolic compound 
(Alhakmani et al., 2013). MO has been consumed because it poses some medicinal 
properties that act as antitumor, antipyretic, cardiac and circulatory stimulants, 
antiulcer, antiepileptic, anti-inflammatory, antispasmodic, diuretic, liver disease, 
antihypertensive, cholesterol lowering, antioxidant, antifungal, hepatoprotective, 
antibacterial, diabetes mellitus and antidiabetic activities (Kumar et al., 2010). MO 
also has been reported contains of compounds like glucosinolates, isothiocyanates, 
kaempferol, rhamnetin, quercetin, isorhamnetin, isoquercetin and more (Leone et al., 
2015). However, the extensive research needs to be done to gain more information 
on the effect of MO that could be able to inhibit several major mechanisms in cancer 
development (Karim et al., 2016).  
 
1.2 Problem statement 
A few studies carried out abroad have proven the effectiveness of MOL as an 
anticancer agent on several type of cancer cells. However, there is still lack of 
information on apoptosis death mechanism pathway in MCF-7 cells. Therefore, this 
study would be beneficial to further explore the cytotoxicity effect of MOL extract 
on induction of death mechanism pathway in MCF-7 cells that could be act through 
induction of apoptosis pathways. Besides that, this study also focus on the 
effectiveness of fraction solvent extracts from various degree of polarities that had 
been not done yet on cytotoxicity effect of MCF-7 cells. The flow of research study 
can be referred to Figure 1.1. 
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1.3 Objectives of study 
The objectives of this study are: 
1. To investigate the cytotoxicity effect of MOL extracts on MCF-7 cells. 
2. To analyze phytochemical contents of MOL extract by GC-MS. 
3. To determine the death mechanism pathway through induction of apoptosis 
on MCF-7 cell treated with MOL extract by western blot analysis. 
  
5 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Flow chart of study 
Partition/Fractionation 
30 g CME-MOL 
           ↓ 
Hexane + water (3:1) 
(HF-CME-MOL)    ↓ 
         Dichloromethane + water 
                (DF-CME-MOL)           ↓ 
                                 Chloroform + water 
                                   (CF-CME-MOL)                 ↓ 
                                                    n-Butanol + water 
                                                    (nBF-CME-MOL)       ↓ 
                                                                      Aqueous 
                                                                                                                        (AR-CME-MOL) 
Cytotoxicity assay 
→ Crude 80 % methanol and its fractions MOL extract were  
treated on MCF-7 and MCF-10A cell line for 72 H. 
→  Extract with lowest IC50 and greatest SI was chosen  
      (In this study was DF-CME-MOL). 
→ The chosen extract further treated on MCF-7 cell line for 24 
H and 48 H to confirm lowest IC50 at 72 H is the lowest. 
→  Morphological change observed under inverted microscope. 
Data analysis 
Mechanism pathway of 
apoptosis by western blotting 
→ 80 % methanol (CME-MOL) 
Chemical profiling 
→ GC-MS analysis 
→ Antioxidant activity by DPPH and ABTS assay 
→ TPC by Folin-ciocalteu method 
→ TFC by aluminium chloride colorimetric method 
Apoptosis analysis 
by flow cytometry 
→ 80 % methanol 
(CME-MOL) 
Moringa oleifera leaves extraction 
Maceration 
→ 80 % methanol (CME-MOL) 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Moringa oleifera 
2.1.1 Introduction and its importance as a medicinal plant 
Moringa oleifera Lam. (MO) is a well known species among thirteen species 
of the family Moringaceae (Table 2.1). It is usually recognized as Drumstick tree, 
Ben Oil tree, Miracle tree, Horseradish tree and West Indian Ben tree (Anwar et al., 
2007), while in the Philippines, it is recognized as „Mother‟s best friend‟ because it 
can be used as milk booster (Kumar et al., 2010). However, in Malaysia, it is known 
as Munggai or Kelor tree. 
 
MO is a valuable plant that composed as various of medicinal properties. MO 
provide an important source of new drugs and potential pharmaceutical compounds 
because of containing several phytochemicals which beneficial in medicinal 
properties (Berkovich et al., 2013). 
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Table 2.1   Other well-known of varieties species of Moringa. 
Family Species Reference 
 M. arborea Daba, 2016 
 M. borziana  
 M. concanensis  
 M. drouhardii  
 M. hildebrandtii  
Moringacae M. longitude  
 M. ovalifolia  
 M. peregrina  
 M. pygmaea  
 M. rivae  
 M. ruspoliana  
 M. stenopetala  
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All parts of this plant: leaves, roots, seed, bark, fruit, flowers and immature 
pods contain a profile of important minerals and are a good source of protein, β-
carotene, vitamins, amino acids, flavonoids and various phenolic (Moyo et al., 2011). 
As stated by Gopalakrishnan et al. (2016), the amounts of 11 elements in the MO 
leaves samples have been found specifically, which are the macronutrients: 
potassium, phosphorus, magnesium, calcium, and the micronutrients: copper, iron, 
manganese, zinc, boron, aluminium and sodium. This kind of mineral compounds 
can be extracted using solvent extraction (Zhao and Zhang, 2013). 
 
There have many usage of every part of MO tree (Table 2.2) such as water 
purification from powdered seeds (Anwar et al., 2007, Sengupta et al., 2012 and Al-
Anizi et al., 2014), medicine from all plant parts (Fahad et al., 2010) and malnutrient 
juice expressed from the leaves contain more iron than spinach, more vitamin C than 
oranges, more potassium than bananas and more calcium than milk which are usually 
used for infants and nursing mothers (Fahey, 2005). In Malaysia, the young tender 
pods of fruit are used for cooking which cut into small pieces and added to curries 
(Abdulkarim et al., 2005). 
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Table 2.2   The usage of each part of Moringa oleifera tree. 
Parts of Moringa oleifera Uses References 
Leaves 1. Natural medicines 
2. Human food 
3. Animal Fodder 
4. Cleaning agent 
5. Natural pesticide 
Daba, 2016 
Flowers 1. Source of nectar 
2. Natural medicines 
3. Human food 
Seeds 1. Oil production 
2. Water purification 
3. Natural medicines 
4. Human food 
5. Cosmetic 
6. Lubricant 
7. Fertiliser 
Pods 1. Natural medicines 
2. Human food 
Bark 1. Natural medicines 
2. Animal Fodder 
3. Fuelwood 
4. Rope/mats and 
paper 
Gum 1. Natural medicines 
2. Human food 
Roots 1. Natural medicines 
2. Human food 
3. Alley cropping 
Resin 1. Textile industry 
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Besides that, as stated by Kumar et al. (2010), MO also can act as antitumor, 
antibacterial, antifungal activities, antipyretic, antiepileptic, anti-inflammatory, 
antiulcer, antispasmodic, diuretic, antihypertensive, cholesterol lowering, 
antioxidant, antidiabetic, hepatoprotective, and can be effected for the treatment of 
various diseases in the indigenous system of medicine. MO also has potential to 
promote normal blood-glucose level, support immune system, enrich the anemic 
blood, improves eyesight, mental alertness, bone strength, burst lactating mothers, 
menopause, depression, osteoporosis (Mahmood et al., 2010). In addition, Rathi et al. 
(2006) concluded that the aqueous extract of MO had wound healing property.  
 
MO also has been used in folk medicine revealed for centuries from 
generation to generation in many cultures around the world to treat anaemia, anxiety, 
skin infections, blackheads, asthma, bronchitis, blood impurities, chest congestion, 
infections, fever, glandular, cholera, swelling, scurvy, headaches, hysteria, pain in 
joints, psoriasis, pimples, respiratory disorders, abnormal blood pressure, semen 
deficiency, tuberculosis, sore throat, sprains,  pregnancy and for intestinal worms 
(Mishra et al., 2012). Bakre et al. (2013) also reported that MO is traditionally used 
for the treatment of epilepsy and neurologic conditions. MO also has been suggested 
as a viable supplement of dietary minerals (Farooq et al., 2012). 
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2.1.2 Distribution of Moringa oleifera 
MO is an important crop and grow wild especially in Sudan, India, 
Philippines, Ethiopia, and being grown in Tropical Asia, East, West and South 
Africa, Latin America, Florida, Caribbean and the Pacific Islands (Figure 2.1 and 
Figure 2.2) (Fahey, 2005; Khalafalla et al., 2010; Paul and Didia et al., 2012). This 
plant can be propagated through sexual and/or asexual because it not demand for 
high soil nutrients and water hence, easy to handle and manage its planting (Adedapo 
et al., 2009). However, MO has been introduced as a field crop for production of 
biomass by propagating its seed (Nouman et al., 2012). It cultivates in many tropical 
and subtropical country with irregular environmental features with annual 
precipitation of 760 to 2500 mm, temperature between 18 to 28 °C and pH between 
4.5 to 8, at an altitude up to 2000 m (Leone et al., 2015). It normally cultivated 
throughout the plains area especially in borders and in-house yards, grow well under 
the tropical climate and are abundant near the streams and sandy of rivers (Adedapo 
et al., 2009). In addition, it can cultivate well in hot dry lands or moist tropics and 
can survive on insolvent soils with little effect by drought tolerance (Zhao and 
Zhang, 2013).  
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Figure 2.1   Places of M. oleifera grows (Adapted from Trees for life, 2005). 
 
 
Figure 2.2   Places of M. oleifera needed as food sources and medicinal drug 
treatment (Adapted from Trees for life, 2005). 
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2.1.3 Morphology of Moringa oleifera tree 
This tree normally grows up between 10 to 12 m in height with whitish, soft, 
thick and corky bark (Figure 2.3). The tree spreading by an open crown of drooping 
with brittle branches, feathery foliage of tripinnate leaves and some parts such as 
flowers, fruits, roots and seed oil (Dao and Kabore, 2015). According to Zhigila et al. 
(2015), leaves shapes are tripinnate (with long up to 45 cm), alternate and spirally 
arranged on the twigs. Its structure is hairy, green on the upper surface, paler and 
hairless on the lower surface (Figure 2.4 (A)). The branches are finely hairy and 
green but turn brown when mature. According to Paliwal et al. (2011), the color of 
the flower is yellowish-white with a 10-25 cm long, five spathulate petals, five 
smaller stamens, five staminodes, and thinly veined (Figure 2.4 (B)). Paliwal et al. 
(2011) also described the fruits are linear, pendulous, three-sided pods with nine 
longitudinal ridges and usually long between 20 to 50 cm (Figure 2.4 (C)). 
However, its fruit can longer more than 1 m, and 2.0 to 2.5 cm broad. In pod‟s fruit, 
normally contains the seed about 26 seeds. The color of seed is dark green in early 
development and takes around three months to mature after flowering. They chance 
to brown during maturity and split open longitudinally along the three angles, 
spreading the dark brown of trigonous seeds (Figure 2.4 (D)). The measurement of 
seeds about 1 cm in diameter, with three whitish thin wings on the angles. Seed 
weights differ among variabilities, ranging between 3,000 to 9,000 seeds per 
kilogram (Paliwal et al., 2011).   
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Figure 2.3   Moringa oleifera tree (Adapted from Chaudhary and Chaurasia, 2017).  
 
  
 
 
Figure 2.4   Part of Moringa oleifera tree: (A) Leaves (B) Flowers (C) Fruits and (D) 
Seeds (Adapted from Chaudhary and Chaurasia, 2017). 
 
A B 
C D 
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2.1.4 Bioactive compound of M. oleifera as medicinal plant 
The bioactive compounds are usually referred as functional ingredients and 
responsible in the functional bioactivities (Ibañez et al., 2012). Bioactive compounds 
in the plant are known as secondary metabolites because it derived from the primary 
metabolites (Chikezie et al., 2015). The secondary metabolites gave a diverse range 
of toxicological or pharmacological effects in human and animal system (Bernhoft, 
2010). Primary constituents include the common sugars, purines and pyrimidines of 
nucleic acids, amino acid of proteins, chlorophyll‟s etc., while secondary constituents 
include terpenes (a group of lipids), alkaloids (derived from amino acids), and 
phenolics (derived from carbohydrates) (Sen and Chakraborty, 2011). The 
production of secondary metabolites in specific pathway and site of synthesis 
depends on plant species (Yazdani et al., 2011). Secondary metabolites have played 
important role in various biological activities such as anticancer, antioxidant, 
antimicrobial, antihepatotoxic, antileprosy, antimalarial, anticholinergic, 
hypoglycemic, hepatoprotective, CNS depressant and mutagenicity (Negi et al., 
2011).  
 
Merina et al. (2012) and Sharma et al. (2011) reported that MO tree was used 
in folk remedies for tumors. The present study deals with the isolation of bioactive 
compounds by maceration and fractionation of extraction from MO leaves by using 
different polarity of solvents to make sure the possible of bioactive compounds 
which possess to anticancer and antioxidant were extract out. Phytochemical studies 
have shown that MO contains compounds with diverse chemical classes such as 
quercetin, kaempferol, niazimicin, beta-sitosterol, zeatin, vanillin, glucosinolates, 
isothiocyanate, saponins and tannins that are believed to have anticancer activities 
(Atawodi et al., 2010; Baraya et al., 2014). Isothiocyanate has antitumor activity in 
cancers of breast, lung, esophagus, skin, and pancreas (Merina et al., 2012). The 
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specific components in MO extract can be attributed to the anticancer property such 
as 4-(α-L-rhamnopyranosyloxy) benzyl isothiocyanate, 4-(α-L-rhamnopyranosyloxy) 
benzyl glucosinolates and benzyl isothiocyanate (Tiloke et al., 2013). 
 
Ferreira et al. (2008) stated that all parts of MO are contain renewable 
sources like phenolic compounds, tocopherols (α and γ), vitamin C, ß-carotene, and 
total proteins, including the amino acids, sulfur, cysteine and methionine which acts 
as antioxidant compound. Al-Asmari et al. (2015) revealed numerous known 
anticancer compounds in MO leaves, bark and seed extract, namely isopropyl 
isothiocyanate, eugenol, hexadecanoic acid ethyl ester and D-allose.  Karthika et al. 
(2013) reported that MO leaves extract can be acted against bacterial or fungal skin 
due to the presence of 1, 2-Benzene-dicarboxylic acid, diethyl ester, linalool oxide 
and palmitic acid. The present of bioactive compounds in plant extracts can be 
detected by using phytochemical screening assays, chromatographic techniques 
(TLC, HPLC, LC-MS, and GC-MS) and non-chromatographic techniques 
(immunoassay and FTIR) (Sasidharan et al., 2011).  
 
2.1.5 Induction of apoptosis by Moringa oleifera in cancer cells 
Solvent and aqueous extracts of MO have been reported to have significant 
antiproliferative effects on several type of cancer cells such as breast, colon, alveolar 
and pancreatic cell and induce apoptosis in KB, HeLa, HepG2, A549, MDA-MDB 
231, HCT-8, and Panc-1 cells. For example, Charoensin (2014) carried out the study 
using two-stage of MO leaves extraction by using dichloromethane and methanol 
solvents. Both extracts were treated on breast cancer cell (MCF-7), colorectal cancer 
cell (Caco-2), and hepatocellular carcinoma (HepG2) to determine efficacy of  
growth inhibition. The extracts were significantly inhibit the proliferation of cancer 
cells in dose dependent manner but, unaffected on cell growth of normal human 
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fibroblast. However, their study lack of information about the knowledge of 
apoptosis inductions. 
 
On the other hand, there have several pre-clinical research study had 
confirmed the ability of leave, seed, and bark of MO to induce apoptosis in various 
cancer cell leading their death mechanism pathways by activation or inhibition of 
apoptosis. According to Tiloke et al. (2013) study, hot water extract of MO leaves 
was induced apoptosis in A459 lung cancer cells by upregulating expression of pro-
apoptotic proteins such as p53, Smac/DIABLO, downregulating expression of anti-
apoptotic protein (Nrf2), and cleavage of PARP-1. Therefore, increased activities of 
caspase 3, 7 and 9 in treated A459 cells. In a related study, Jung (2014) proved that 
cold aqueous extract of MO leaves had been reported to trigger apoptosis in lung 
cancer cells (A549) through mitochondrial mediated pathway by activation of pro-
caspase 3 to caspase 3. Additionally, the staining of propidium iodide (PI) on 
membrane integrity of A549 cells were also observed where PI was able to penetrate 
the membrane and attached to nucleic acid in the cytoplasm.  
 
Additionally, according to the study by Sreelatha et al. (2011), hot water of 
MO leaves extract had triggered apoptosis in KB cells. PI and DAPI staining of 
treated KB cells revealed that the cells were permeable to PI which suggested that 
apoptosis had occurred. Moreover, DAPI staining was double confirmed the 
presence of nuclear changes peculiar to apoptotic cell death such as the appearance 
of condensed and fragmented chromatin. Also, study by Berkovich et al. (2013) 
reported that hot water of MO leaves extract induced apoptosis in Panc-1 cells by 
downregulating an expression of NF-kβ signalling pathway. 
 
 
  
18 
 
While, Al-Asmari et al. (2015) study showed that ethanolic extracts of MO 
leaves and barks induced apoptosis in MDA-MDB-231 cells and HCT8 cells. 
However, ethanolic extract of MO seeds mildly triggered apoptosis in HCT8 cells 
only. Their study were done by using double staining of annexin V and PI techniques 
where annexin V binds to translocated phosphatidylserine (PS) on the outer surface 
of cell membrane caused by apoptosis and PI passes through cell membrane when 
the membrane integrity has been compromised due to necrosis cell death and 
intercalate into nucleic acid of cell cytoplasm. 
 
Hermawan et al. (2012) study was also proved that ethanolic of MO leaves 
extract treated on HeLa cells were detected apoptotic bodies. Then, the apoptosis cell 
death was further enhanced in the HeLa cells when treated with a combined drug of 
100 nM doxorubicin and 250 µg/mL of MO leaves extract. Besides that, Jung et al. 
(2015) showed that a potential oral anticancer drug  of cold water extract of MO 
leaves induced apoptosis on HepG2 cells by activating caspase 3 via cleavage and 
downregulating the expression of Bcl-xL anti-apoptotic protein. 
 
However, further molecular study are required to understand the mechanism 
action of the plants parts by focusing on the cytotoxicity effect of different degree of 
solvent polarities extractions as continued in this present study. 
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2.2 Cancer  
The field of this study known as oncology. However, there have certain fields 
can be related to cancer research such as cell and molecular biology, chemistry, 
physiology, epidemiology, anatomy, and other related fields (American Cancer 
Society, 2014). 
 
Cancer proliferation involves multiple process (Figure 2.5) as following: 1) 
initiation, 2) promotion, 3) progression, 4) invasion, and 5) metastasis (Siddiqui et al., 
2015). Cancer can occur when DNA damage is a failure to repair and lead to genetic 
mutation. This damaged cell caused by somatic mutation can be duplicated during 
division of mitosis, hence give chance to clone of mutated cells. Therefore, the 
promotion of tumor can further initiate cells to produce an active proliferation of 
multicellular premalignant tumor cell population that developed through a process of 
clonal expansion. Finally, cancer development, invasion, and metastasis happen in 
the late stages of cancer where tumor cells detach from primary tumor mass and 
migrate through neighboring tissues toward blood vessels or lymphatic vessels and 
create a second lesion. When this happens, it accumulates the cancer regulating 
genes become changing in oncogenes and/or tumor suppressor genes, resulting in 
decreased apoptosis, increase proliferation, cell maturation, and differentiation (Dai 
and Mumper, 2010). 
 
Figure 2.5 Carcinogenesis phases (Adapted from Siddiqui et al., 2015). 
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There are many types of cancer in this world. The most common cancer and 
widely occurs are lung cancer (1.82 million), breast cancer (nearly 1.67 million) and 
colorectal cancer (nearly 1.36 million) (Farley et al., 2014). However, breast cancer 
is the most common cancer among females followed by cervical cancer while 
colorectal cancer is increasing in dominance in both sexes (Pharmaceutical 
Association of Malaysia, 2009-2015). 
 
2.2.1 Breast cancer 
Breast cancer can be classified into different subgroups depending on the 
expression of progesterone receptor (PR), estrogen receptor (ER) and human 
epidermal growth factor receptor 2 (HER2) (Liu et al., 2014). Breast cancer is 
derived from carcinoma of breast and start growing in an abnormal way, thus it is 
causing to malignant tumor. The process happens is called as metastasis where 
cancer cell spreads out to other parts of the body and begin to destruct other tissues 
and organ usually includes the lungs, liver, bones or brain (Rahman and Mohammed, 
2015). 
 
There have several categories of a tumor; 1) non-invasive breast cancer 
benign stay in one spot without spread to other cell or organ and 2) invasive breast 
cancer spread other parts of the body. Somehow, breast cancer also can occur at the 
specific cell surface receptors which are progesterone receptor (PR), estrogen 
receptor (ER) and human epidermal growth factor receptor (HER)2/neu receptor 
(Zaha, 2014). 
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The types of breast cancer that caused by these receptors are known as 
HER2-positive breast cancer, HER2-negative breast cancer, hormone receptor-
positive breast cancer and triple negative breast cancer (TNBC). HER2-positive 
breast cancer cell is express too much of a protein HER2/neu, HER2-negative do not 
overexpress a protein HER2/neu and hormone receptor-positive breast cancer in 
response to the hormones estrogen and progesterone (Iqbal, 2016). But TNBC does 
not respond or overexpress to receptors of estrogen, progesterone, and HER2/neu 
(Podo et al., 2010). 
 
While, the symptoms of breast cancer are 1) new lump in or near breast or 
under arm, 2) swelling on a part of breast, 3) irritation, 4) redness on breast or nipple 
area, 5) nipple pulling inside or pain around nipple area, 6) liquid discharge other 
than breast milk that occurs without squeezing and 7) change in size or shape of 
breast (American Cancer Society, 2017).  
 
2.2.2 Breast cancer cell line (MCF-7 cells) 
In cancer research, cancer cell line is widely used and has been established as 
a model of human cancer for specific disease types since it is ubiquitous and used for 
our better understanding in cells and molecular activity, gene expression, its function 
or malfunction, interaction with other cells, physiology changes and therapeutic 
strategies (Keen, 2011). It was maintained by sub culturing under certain conditions 
in a laboratory. Cancer cell lines are used in research to study the biology of cancer 
and to test cancer treatments (in vitro study) (Gillet et al., 2013). 
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In the recent study, the type breast cancer cell line used is MCF-7 
(adenocarcinoma type). MCF-7 has been established in 1973 at the Michigan Cancer 
Foundation-7 (MCF-7) (Soule et al., 1973). It is an invasive human breast cancer that 
expresses ER (Lee et al., 2015). It was predicted as MCF-7 ER-positive cell line 
where estrogen-stimulated tumor growth directly (Levenson and Jordan, 1997). 
According to Holliday and Speirs (2011), ER is a therapeutic target. Besides that, it 
is most commonly used in the world as an experimental tool in cancer research 
because they compromise an unlimited supply of a relatively standardized cell 
population where they capable of self-replication in standard cell culture medium. 
Zaha (2014) stated that PR, ER, HER2, Ki-67, and p53 are the most common used in 
immunohistochemical breast cancer prognostic and therapeutic markers. 
 
2.3 Cancer metabolism pathway 
The programmed cell death process happens naturally to control and balances 
cell proliferation by eliminating the damaged cells. In our body system, there are 
three type of program cell death and their mechanism are different. Apoptosis 
(known as Type I programmed cell death) is committing to suicide (Figure 2.6), 
autophagy (known as Type II programmed cell death) is maintaining cytoplasmic 
membranes and cell body and completely removed without any inflammation 
(Figure 2.7) while necrosis (known as Type III programmed cell death) is murdering 
the cells (Figure 2.6). These three distinct types of cell death are specifying for the 
fate of cell (Ouyang et al., 2012). In addition, the form of cell death depends on the 
genotype of cell, type of cell, type of DNA mutation and dose of sample used (Fulda 
and Debatin, 2006). All types of programmed cell death can be distinguishable based 
on morphological features as shown in Table 2.3. 
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Table 2.3   Morphology features of apoptosis, autophagy, and necrosis. 
Type of cell death Morphology features References 
Apoptosis 1. Nuclear changes (nuclear 
chromatin condensation and 
nuclear fragmentation) 
2. Membrane blebbing (cause 
losing attachment with adjacent 
cells) 
3. Cell contraction/shrinkage 
4. Form apoptotic bodies. 
Mollazadeh et al. 
(2015) 
Autophagy 1. Formation of autophagosome, 
2. Cytoplasmic macromolecules 
3. Organelles surrounded by 
double membrane-bound 
structures. 
Parzych and Kliansky 
(2014) 
Necrosis 1. Swelling of cell 
2. Dysfunction of organelle 
3. Disrupted cell membrane 
4. Cell lysis. 
Nikoletopoulou et al. 
(2013) 
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Figure 2.6   Diagram of apoptosis and necrosis (Adapted from Thinkstock, 2016). 
 
 
Figure 2.7   Diagram of autophagy (Adapted from Biophagy, 2013). 
